Somaxon Pharmaceuticals, Inc. 4
4 · Somaxon Pharmaceuticals, Inc. · Filed Sep 28, 2006
Insider Transaction Report
Form 4
Dube Susan
Senior VP, Corp and Bus Dev
Transactions
- Sale
Common Stock
2006-09-26$12.62/sh−600$7,574→ 74,400 total(indirect: By Trust)
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Susan E. Dube, Trustee U.T.D. May 6, 2002 on 09/18/2006.